Researchers in this study wanted to understand how common breast cancer treatments—specifically endocrine therapies like tamoxifen and aromatase inhibitors—affect body weight and metabolism. Many breast cancer survivors report gaining weight during treatment, but the biological reasons behind this are not fully understood.
To investigate this, researchers used experimental models to study how these therapies affect body fat (adipose tissue) and metabolism. They compared the effects in individuals with different body types, including those who were lean and those who were obese.
They found that endocrine therapy led to increased body weight and fat accumulation, but the effects differed depending on body type. In lean individuals, treatment caused increases in fat storage, while in obese individuals, it led to changes in how fat tissue functioned. These therapies also affected how the body processes energy and stores fat, suggesting broader metabolic impacts.
Overall, the study shows that breast cancer treatments can have significant effects on body composition and metabolism, beyond their role in treating cancer.
